Loading live market data…

Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

$10.79 USD

-$0.24 (-2.22%)

Volume
413.04K
Average Volume
1.24M
Market Capitalization
$860.57M
P/E Ratio
-5.09
Dividend Yield
0.00%
Price Target
$23.00
Year High
$18.31
Year Low
$7.61
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.21

PHAT Estimated and Actual Revenue by Quarter

PHAT Estimated and Actual EPS by Quarter

PHAT Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 1 -38.49M -36.36M -37.38M -38.65M -36.51M -37.53M
2028-09-30 1 -34.37M -32.46M -33.37M -34.51M -32.59M -33.51M
2028-06-30 1 -30.69M -28.99M -29.8M -30.82M -29.11M -29.93M
2028-03-31 1 -27.39M -25.87M -26.6M -27.5M -25.98M -26.71M
2027-12-31 2 -28.26M -26.69M -27.44M -28.38M -26.8M -27.55M
2027-09-30 2 -24.78M -23.41M -24.07M -24.89M -23.5M -24.17M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 1 76.76M 82.68M 79.59M 7.59B 8.03B 7.8B
2028-09-30 1 63.31M 68.19M 65.64M 6.78B 7.17B 6.97B
2028-06-30 1 51.44M 55.4M 53.33M 6.05B 6.41B 6.22B
2028-03-31 1 39.57M 42.62M 41.03M 5.4B 5.72B 5.55B
2027-12-31 2 45.71M 49.24M 47.4M 5.57B 5.9B 5.73B
2027-09-30 2 32.49M 34.99M 33.69M 4.89B 5.17B 5.02B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 1 208.73M 221.01M 214.6M 1 0.93552 1.00766 0.97
2028-09-30 1 186.36M 197.32M 191.6M 1 0.77156 0.83106 0.8
2028-06-30 1 166.42M 176.21M 171.1M 1 0.6269 0.67524 0.65
2028-03-31 1 148.52M 157.26M 152.7M 1 0.48223 0.51941 0.5
2027-12-31 2 153.23M 162.24M 157.53M 1 0.55715 0.60011 0.57768
2027-09-30 2 134.39M 142.29M 138.17M 1 0.39596 0.42649 0.41055